Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction.

MLA

Chen, Mu-Hong, et al. “Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction.” International Journal of Neuropsychopharmacology, vol. 25, no. 2, Feb. 2022, pp. 99–105. EBSCOhost, https://doi.org/10.1093/ijnp/pyab068.

APA

Chen, M.-H., Liu, Y.-L., Kuo, H.-W., Tsai, S.-J., Hsu, J.-W., Huang, K.-L., Tu, P.-C., & Bai, Y.-M. (2022). Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction. International Journal of Neuropsychopharmacology, 25(2), 99–105. https://doi.org/10.1093/ijnp/pyab068

Chicago

Chen, Mu-Hong, Yu-Li Liu, Hsiang-Wei Kuo, Shih-Jen Tsai, Ju-Wei Hsu, Kai-Lin Huang, Pei-Chi Tu, and Ya-Mei Bai. 2022. “Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction.” International Journal of Neuropsychopharmacology 25 (2): 99–105. doi:10.1093/ijnp/pyab068.